tegafur has been researched along with Lung Adenocarcinoma in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of postoperative tegafur-uracil on overall survival (OS) after resection of stage I adenocarcinoma has been shown in clinical trials." | 9.69 | Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis. ( Aoyama, A; Date, H; Date, N; Fujinaga, T; Fukada, T; Hamaji, M; Huang, CL; Ishikawa, M; Katakura, H; Kayawake, H; Kobayashi, M; Kono, T; Matsumoto, A; Menju, T; Miyahara, R; Miyamoto, E; Miyata, R; Morita, S; Nakagawa, T; Nakakura, A; Okumura, N; Sakaguchi, Y; Sakai, H; Shimazu, Y; Sonobe, M; Sumitomo, R; Takahashi, M, 2023) |
| "A phase I dose-escalation study was performed to investigate the safety and pharmacokinetics of the combination of S-1 and gefitinib in patients with pulmonary adenocarcinoma who had failed previous chemotherapy." | 9.17 | Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung. ( Azuma, K; Daga, H; Hayashi, H; Kiyota, H; Miyazaki, M; Murakami, H; Naito, T; Nakagawa, K; Okada, H; Okamoto, I; Takeda, K; Takeda, M; Tanaka, K; Terashima, M; Yamamoto, N, 2013) |
| "When we examine a patient with symptoms of acute enteritis in the course of chemotherapy with oral fluoropyrimidines such as uracil-tegafur (often referred to as UFT), we usually suspect 5-fluorouracil-induced enterocolitis." | 7.83 | Cytomegalovirus colitis in a patient undergoing postoperative adjuvant chemotherapy for lung adenocarcinoma with uracil-tegafur. ( Abe, N; Fujinaga, A; Hayashi, H; Hirata, K; Ito, K; Komatsu, Y; Matsuda, K; Uchida, T, 2016) |
| "The effect of postoperative tegafur-uracil on overall survival (OS) after resection of stage I adenocarcinoma has been shown in clinical trials." | 5.69 | Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis. ( Aoyama, A; Date, H; Date, N; Fujinaga, T; Fukada, T; Hamaji, M; Huang, CL; Ishikawa, M; Katakura, H; Kayawake, H; Kobayashi, M; Kono, T; Matsumoto, A; Menju, T; Miyahara, R; Miyamoto, E; Miyata, R; Morita, S; Nakagawa, T; Nakakura, A; Okumura, N; Sakaguchi, Y; Sakai, H; Shimazu, Y; Sonobe, M; Sumitomo, R; Takahashi, M, 2023) |
| "A phase I dose-escalation study was performed to investigate the safety and pharmacokinetics of the combination of S-1 and gefitinib in patients with pulmonary adenocarcinoma who had failed previous chemotherapy." | 5.17 | Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung. ( Azuma, K; Daga, H; Hayashi, H; Kiyota, H; Miyazaki, M; Murakami, H; Naito, T; Nakagawa, K; Okada, H; Okamoto, I; Takeda, K; Takeda, M; Tanaka, K; Terashima, M; Yamamoto, N, 2013) |
| "When we examine a patient with symptoms of acute enteritis in the course of chemotherapy with oral fluoropyrimidines such as uracil-tegafur (often referred to as UFT), we usually suspect 5-fluorouracil-induced enterocolitis." | 3.83 | Cytomegalovirus colitis in a patient undergoing postoperative adjuvant chemotherapy for lung adenocarcinoma with uracil-tegafur. ( Abe, N; Fujinaga, A; Hayashi, H; Hirata, K; Ito, K; Komatsu, Y; Matsuda, K; Uchida, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 6 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Noro, R | 1 |
| Honda, K | 1 |
| Nagashima, K | 1 |
| Motoi, N | 1 |
| Kunugi, S | 1 |
| Matsubayashi, J | 1 |
| Takeuchi, S | 1 |
| Shiraishi, H | 1 |
| Okano, T | 1 |
| Kashiro, A | 1 |
| Meng, X | 1 |
| Yoshida, Y | 1 |
| Watanabe, S | 1 |
| Usuda, J | 1 |
| Inoue, T | 2 |
| Wilber, H | 1 |
| Ikeda, N | 1 |
| Seike, M | 1 |
| Gemma, A | 1 |
| Kubota, K | 1 |
| Miyata, R | 1 |
| Hamaji, M | 1 |
| Nakakura, A | 1 |
| Morita, S | 1 |
| Shimazu, Y | 1 |
| Ishikawa, M | 1 |
| Kayawake, H | 1 |
| Menju, T | 1 |
| Sakaguchi, Y | 1 |
| Sonobe, M | 1 |
| Takahashi, M | 1 |
| Aoyama, A | 1 |
| Sumitomo, R | 1 |
| Huang, CL | 1 |
| Kono, T | 1 |
| Miyahara, R | 1 |
| Matsumoto, A | 1 |
| Katakura, H | 1 |
| Fukada, T | 1 |
| Sakai, H | 1 |
| Kobayashi, M | 1 |
| Okumura, N | 1 |
| Date, N | 1 |
| Fujinaga, T | 1 |
| Miyamoto, E | 1 |
| Nakagawa, T | 2 |
| Date, H | 1 |
| Tsukita, Y | 1 |
| Inoue, A | 1 |
| Sugawara, S | 1 |
| Kuyama, S | 1 |
| Harada, D | 1 |
| Tanaka, H | 2 |
| Watanabe, K | 1 |
| Mori, Y | 1 |
| Harada, T | 1 |
| Hino, T | 1 |
| Fujii, M | 1 |
| Ichinose, M | 1 |
| Tabe, C | 1 |
| Okumura, F | 1 |
| Shiratori, T | 1 |
| Ishioka, Y | 1 |
| Itoga, M | 1 |
| Taima, K | 1 |
| Morimoto, T | 1 |
| Kimura, D | 1 |
| Tsushima, T | 1 |
| Tasaka, S | 1 |
| Kamiyoshihara, M | 1 |
| Yazawa, T | 1 |
| Igai, H | 1 |
| Matsuura, N | 1 |
| Yoshikawa, R | 1 |
| Ohsawa, F | 1 |
| Kawamoto, N | 1 |
| Okita, R | 1 |
| Hayashi, M | 1 |
| Okada, M | 1 |
| Inokawa, H | 1 |
| Kumagai, T | 1 |
| Kimura, M | 1 |
| Tamiya, M | 1 |
| Nishino, K | 1 |
| Imamura, F | 1 |
| Kawakita, R | 1 |
| Fusumae, T | 1 |
| Oda, S | 1 |
| Takeuchi, A | 1 |
| Takasugi, A | 1 |
| Yoshida, T | 1 |
| Izumi, H | 1 |
| Touge, H | 1 |
| Igishi, T | 1 |
| Makino, H | 1 |
| Nishii-Ito, S | 1 |
| Takata, M | 1 |
| Nakazaki, H | 1 |
| Ueda, Y | 1 |
| Matsumoto, S | 1 |
| Kodani, M | 1 |
| Kurai, J | 1 |
| Takeda, K | 2 |
| Sakamoto, T | 1 |
| Yanai, M | 1 |
| Tanaka, N | 1 |
| Nirodi, CS | 1 |
| Shimizu, E | 1 |
| Hayashi, H | 2 |
| Komatsu, Y | 1 |
| Uchida, T | 1 |
| Abe, N | 1 |
| Ito, K | 1 |
| Hirata, K | 1 |
| Matsuda, K | 1 |
| Fujinaga, A | 1 |
| Nakanishi, K | 1 |
| Sugiyama, K | 1 |
| Abe, Y | 1 |
| Endo, T | 1 |
| Ohsaki, Y | 1 |
| Nagahiro, I | 1 |
| Miyamoto, M | 1 |
| Sugiyama, H | 1 |
| Kawai, T | 1 |
| Toda, K | 1 |
| Nobuhisa, T | 1 |
| Endou, Y | 1 |
| Watanabe, T | 1 |
| Matsumoto, Y | 1 |
| Watanabe, N | 1 |
| Kai, K | 1 |
| Satou, S | 1 |
| Kaneda, H | 1 |
| Okamoto, I | 2 |
| Sakai, K | 1 |
| Tanizaki, J | 1 |
| Takeda, M | 2 |
| Nishio, K | 1 |
| Nakagawa, K | 2 |
| Kiyota, H | 1 |
| Daga, H | 1 |
| Naito, T | 1 |
| Miyazaki, M | 1 |
| Okada, H | 1 |
| Tanaka, K | 1 |
| Terashima, M | 1 |
| Azuma, K | 1 |
| Murakami, H | 1 |
| Yamamoto, N | 1 |
2 reviews available for tegafur and Lung Adenocarcinoma
| Article | Year |
|---|---|
[Persistent Chemotherapy-Induced Hiccups Successfully Treated with Pregabalin].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; D | 2017 |
[A case of drug-induced eosinophilic pneumonia due to tegafur-uracil(UFT®)].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Female | 2011 |
4 trials available for tegafur and Lung Adenocarcinoma
| Article | Year |
|---|---|
Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2023 |
Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoco | 2020 |
Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chem | 2015 |
Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug C | 2013 |
8 other studies available for tegafur and Lung Adenocarcinoma
| Article | Year |
|---|---|
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
Topics: Actinin; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, T | 2022 |
A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer.
Topics: Adenocarcinoma of Lung; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; | 2020 |
[Pulmonary Adenocarcinoma Responding to Fourth-Line S-1 Monotherapy-A Case Report].
Topics: Adenocarcinoma of Lung; Adult; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Lung Neop | 2020 |
Tegafur-uracil-induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report.
Topics: Adenocarcinoma of Lung; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Male; Middle Aged; Pericardi | 2021 |
Delayed pseudoprogression of lung adenocarcinoma accompanied with interstitial lung disease during chemotherapy after nivolumab treatment.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antibodies, Monoclonal; Drug Combinations; Female; Humans; L | 2017 |
Successful treatment of extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant | 2018 |
Cytomegalovirus colitis in a patient undergoing postoperative adjuvant chemotherapy for lung adenocarcinoma with uracil-tegafur.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemot | 2016 |
Marked response to both S-1 and pemetrexed in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Anaplastic Lymphoma Kinase; Antimetabolites, Antineop | 2012 |